Since a number of factors can potentially affect serum irisin levels, to elucidate its precise role in osteoporosis in patients with CKD and renal transplantation, studies with large sample sizes and taking confounding factors into account are necessary. This evidence concerns the gene FNDC5 and chronic kidney disease.